Wade M. Andrew 4
4 · AtriCure, Inc. · Filed Feb 24, 2020
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Wade M. Andrew
Vice President, Finance
Transactions
- Exercise/Conversion
Common Stock
2020-02-21$6.73/sh+15,000$100,950→ 160,120 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-21−15,000→ 0 totalExercise: $6.27From: 2013-10-25Exp: 2022-10-25→ Common Stock (15,000 underlying) - Sale
Common Stock
2020-02-21$39.45/sh−15,000$591,750→ 145,120 total - Sale
Common Stock
2020-02-21$39.45/sh−15,000$591,750→ 145,120 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-21−15,000→ 60,000 totalExercise: $6.73From: 2013-12-27Exp: 2022-12-27→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2020-02-21$6.73/sh+15,000$100,950→ 160,120 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-21−15,000→ 45,000 totalExercise: $6.73From: 2013-12-27Exp: 2022-12-27→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2020-02-21$6.27/sh+15,000$94,050→ 160,120 total - Sale
Common Stock
2020-02-21$39.46/sh−15,000$591,900→ 145,120 total
Footnotes (5)
- [F1]These shares were exercised pursuant to a 10b5-1 trading plan.
- [F2]These shares were sold pursuant to a 10b5-1 trading plan.
- [F3]This transaction was executed in multiple trades at prices ranging from $38.94 to $40.60 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]These options were granted on October 25, 2012. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
- [F5]These options were granted on December 27, 2012 and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.